Burning Rock Biotech (BNR) Other Non-Current Liabilities (2020 - 2025)

Burning Rock Biotech's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 16.33% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 16.33% YoY), while the FY2025 annual figure was $1.7 million, up 19.89% from the prior year.
• Other Non-Current Liabilities was $1.7 million for Q4 2025 at Burning Rock Biotech, up from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $6.5 million in Q3 2022 to a low of $35000.0 in Q1 2021.
• Historically, Other Non-Current Liabilities has averaged $1.3 million across 5 years, with a median of $702000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities jumped 18408.57% in 2022, then sank 92.67% in 2023.
• A 5-year view of Other Non-Current Liabilities shows it stood at $1.8 million in 2021, then plunged by 68.52% to $579851.2 in 2022, then increased by 8.67% to $630132.1 in 2023, then surged by 130.32% to $1.5 million in 2024, then grew by 16.33% to $1.7 million in 2025.
• The last three Other Non-Current Liabilities figures came in at $1.7 million (Q4 2025), $1.6 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.